Virscio, Inc.
New Haven, CT
- UEI
- EYCBWGA47PL5
- CAGE
- 4A9M1
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 5 Science Park #3, New Haven, CT 06511, USA
- Website
- virscio.com
- Founded
- 2002
- Employees
- 51-250
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Neural stem support | Veterans Integrated Service Network 4 | $422,030 | |
| Histological analysis of H9 | Veterans Integrated Service Network 22 | $185,908 | |
| EO MOD 14398 | Veterans Integrated Service Network 22 | $0 | |
| Primate epigenetic and senescence biomarkers to advance aging science and anti-aging strategies. - project summary a… | National Institute on Aging | $291,913 | |
| Amyloid beta oligomer induction of alzheimer disease in nonhuman primates | National Institute on Aging | $3,431,722 |
About Virscio, Inc.
Virscio, Inc. is a for-profit corporate entity registered in SAM.gov since 2006, specializing in translational research focused on advanced biological and medical science. Located in New Haven, Connecticut, the organization appears to be a research-oriented company that develops innovative scientific approaches in areas of aging, neuroscience, and disease prevention. Through federal grant awards, Virscio, Inc. provides specialized research services to federal agencies, with a particular emphasis on developing advanced biomedical research methodologies and conducting intricate scientific investigations.
The company has received federal grant awards primarily from the National Institute on Aging (NIA), demonstrating expertise in aging research and biomarker development. Most recently, Virscio was awarded a $291,913 Project Grant to develop epigenetic and senescent biomarkers using non-human primate tissues, aimed at understanding biological aging processes and potential anti-aging strategies. Additionally, the company has been involved in sub-grant research with Northeastern University on opioid-related studies, specifically focusing on intranasal GDNF gene therapy for opioid relapse reduction. These grant awards indicate Virscio's capabilities in conducting sophisticated scientific research across multiple domains, including aging biology, epigenetics, and neurological disorder interventions. The company's research approach appears to be highly technical, involving advanced methodological techniques such as DNA methylation analysis, biomarker identification, and translational research strategies that bridge animal model studies with potential human health applications.
Quick answers
What is Virscio, Inc.'s UEI?
Virscio, Inc.'s Unique Entity ID (UEI) in SAM.gov is EYCBWGA47PL5.
What is Virscio, Inc.'s CAGE code?
Virscio, Inc.'s CAGE code is 4A9M1.
What is Virscio, Inc.'s primary NAICS code?
Virscio, Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Virscio, Inc. located?
Virscio, Inc.'s physical address in SAM.gov is 5 Science Park #3, New Haven, CT 06511, USA.
Is Virscio, Inc. registered in SAM.gov?
Yes. Virscio, Inc.'s SAM.gov registration is active through December 8, 2026.
What is Virscio, Inc.'s most recent federal award?
Virscio, Inc.'s most recent federal contract award is Neural stem support (36C24E26P0070), from Veterans Integrated Service Network 4, on September 28, 2026.
On GovTribe
See Virscio, Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors